
Jean F. Voltaire
Examiner (ID: 18083, Phone: (571)272-3953 , Office: P/2466 )
| Most Active Art Unit | 2466 |
| Art Unit(s) | 2466, 2417 |
| Total Applications | 487 |
| Issued Applications | 381 |
| Pending Applications | 55 |
| Abandoned Applications | 68 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7801131
[patent_doc_number] => 08129402
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-03-06
[patent_title] => 'Screening molecules with anti-prion activity: kits, methods and screened molecules'
[patent_app_type] => utility
[patent_app_number] => 10/531594
[patent_app_country] => US
[patent_app_date] => 2003-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 9
[patent_no_of_words] => 7450
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/129/08129402.pdf
[firstpage_image] =>[orig_patent_app_number] => 10531594
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/531594 | Screening molecules with anti-prion activity: kits, methods and screened molecules | Oct 19, 2003 | Issued |
Array
(
[id] => 7333522
[patent_doc_number] => 20040131682
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-08
[patent_title] => 'Pulsatile release histamine H2 antagonist dosage form'
[patent_app_type] => new
[patent_app_number] => 10/689566
[patent_app_country] => US
[patent_app_date] => 2003-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4608
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0131/20040131682.pdf
[firstpage_image] =>[orig_patent_app_number] => 10689566
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/689566 | Pulsatile release histamine H2 antagonist dosage form | Oct 19, 2003 | Abandoned |
Array
(
[id] => 580864
[patent_doc_number] => 07452910
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-11-18
[patent_title] => 'Indolyl-3-glyoxylic acid derivatives having therapeutically valuable properties'
[patent_app_type] => utility
[patent_app_number] => 10/686809
[patent_app_country] => US
[patent_app_date] => 2003-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 3984
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/452/07452910.pdf
[firstpage_image] =>[orig_patent_app_number] => 10686809
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/686809 | Indolyl-3-glyoxylic acid derivatives having therapeutically valuable properties | Oct 16, 2003 | Issued |
Array
(
[id] => 4456350
[patent_doc_number] => 07893078
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-02-22
[patent_title] => 'Use of cyclopamine in the treatment of basal cell carcinoma and other tumors'
[patent_app_type] => utility
[patent_app_number] => 10/682584
[patent_app_country] => US
[patent_app_date] => 2003-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 20
[patent_no_of_words] => 6682
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/893/07893078.pdf
[firstpage_image] =>[orig_patent_app_number] => 10682584
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/682584 | Use of cyclopamine in the treatment of basal cell carcinoma and other tumors | Oct 8, 2003 | Issued |
Array
(
[id] => 224984
[patent_doc_number] => 07605167
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-10-20
[patent_title] => 'Use of cyclopamine in the treatment of psoriasis'
[patent_app_type] => utility
[patent_app_number] => 10/682662
[patent_app_country] => US
[patent_app_date] => 2003-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 52
[patent_no_of_words] => 9296
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/605/07605167.pdf
[firstpage_image] =>[orig_patent_app_number] => 10682662
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/682662 | Use of cyclopamine in the treatment of psoriasis | Oct 8, 2003 | Issued |
Array
(
[id] => 4456350
[patent_doc_number] => 07893078
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-02-22
[patent_title] => 'Use of cyclopamine in the treatment of basal cell carcinoma and other tumors'
[patent_app_type] => utility
[patent_app_number] => 10/682584
[patent_app_country] => US
[patent_app_date] => 2003-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 20
[patent_no_of_words] => 6682
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/893/07893078.pdf
[firstpage_image] =>[orig_patent_app_number] => 10682584
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/682584 | Use of cyclopamine in the treatment of basal cell carcinoma and other tumors | Oct 8, 2003 | Issued |
Array
(
[id] => 7469312
[patent_doc_number] => 20040167212
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-26
[patent_title] => 'X-nitro compounds, pharmaceutical compositions thereof and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/681855
[patent_app_country] => US
[patent_app_date] => 2003-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8495
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20040167212.pdf
[firstpage_image] =>[orig_patent_app_number] => 10681855
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/681855 | X-nitro compounds, pharmaceutical compositions thereof and uses thereof | Oct 6, 2003 | Abandoned |
Array
(
[id] => 7169700
[patent_doc_number] => 20040077686
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-22
[patent_title] => 'Inhibition of cyclooxygenase-2 activity'
[patent_app_type] => new
[patent_app_number] => 10/680606
[patent_app_country] => US
[patent_app_date] => 2003-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2360
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20040077686.pdf
[firstpage_image] =>[orig_patent_app_number] => 10680606
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/680606 | Inhibition of cyclooxygenase-2 activity | Oct 6, 2003 | Abandoned |
Array
(
[id] => 5656535
[patent_doc_number] => 20060142271
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-29
[patent_title] => 'Novel lapacho compounds and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/528295
[patent_app_country] => US
[patent_app_date] => 2003-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9226
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20060142271.pdf
[firstpage_image] =>[orig_patent_app_number] => 10528295
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/528295 | Novel lapacho compounds and methods of use thereof | Sep 16, 2003 | Abandoned |
Array
(
[id] => 7674595
[patent_doc_number] => 20040127523
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-01
[patent_title] => 'Methods of treating cancer with HDAC inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/665079
[patent_app_country] => US
[patent_app_date] => 2003-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 24543
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0127/20040127523.pdf
[firstpage_image] =>[orig_patent_app_number] => 10665079
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/665079 | Methods of treating cancer with HDAC inhibitors | Sep 15, 2003 | Abandoned |
Array
(
[id] => 7270411
[patent_doc_number] => 20040058929
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-25
[patent_title] => 'Unit dosage form'
[patent_app_type] => new
[patent_app_number] => 10/661951
[patent_app_country] => US
[patent_app_date] => 2003-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7276
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20040058929.pdf
[firstpage_image] =>[orig_patent_app_number] => 10661951
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/661951 | Unit dosage form | Sep 11, 2003 | Abandoned |
Array
(
[id] => 7207284
[patent_doc_number] => 20040087579
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-06
[patent_title] => 'Enhancement of effectiveness of 5-fluorouracil in treatment of tumor metastases and cancer'
[patent_app_type] => new
[patent_app_number] => 10/660798
[patent_app_country] => US
[patent_app_date] => 2003-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1353
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20040087579.pdf
[firstpage_image] =>[orig_patent_app_number] => 10660798
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/660798 | Enhancement of effectiveness of 5-fluorouracil in treatment of tumor metastases and cancer | Sep 11, 2003 | Issued |
Array
(
[id] => 7255798
[patent_doc_number] => 20050075396
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-07
[patent_title] => 'Use of (-)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of insulin resistance, Type 2 diabetes and hyperlipidemia'
[patent_app_type] => utility
[patent_app_number] => 10/660112
[patent_app_country] => US
[patent_app_date] => 2003-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 16550
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0075/20050075396.pdf
[firstpage_image] =>[orig_patent_app_number] => 10660112
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/660112 | Use of (-)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of insulin resistance, Type 2 diabetes and hyperlipidemia | Sep 9, 2003 | Abandoned |
Array
(
[id] => 7169522
[patent_doc_number] => 20040077660
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-22
[patent_title] => 'Method for treating insulin resistance, abdominal obesity, hypertension, hyperinsulinemia, and elevated blood lipids with a cortisol inhibitor'
[patent_app_type] => new
[patent_app_number] => 10/654809
[patent_app_country] => US
[patent_app_date] => 2003-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1448
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20040077660.pdf
[firstpage_image] =>[orig_patent_app_number] => 10654809
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/654809 | Method for treating insulin resistance, abdominal obesity, hypertension, hyperinsulinemia, and elevated blood lipids with a cortisol inhibitor | Sep 3, 2003 | Issued |
Array
(
[id] => 7674648
[patent_doc_number] => 20040127470
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-01
[patent_title] => 'Methods and compositions for the prevention or treatment of neoplasia comprising a Cox-2 inhibitor in combination with an epidermal growth factor receptor antagonist'
[patent_app_type] => new
[patent_app_number] => 10/651916
[patent_app_country] => US
[patent_app_date] => 2003-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60266
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0127/20040127470.pdf
[firstpage_image] =>[orig_patent_app_number] => 10651916
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/651916 | Methods and compositions for the prevention or treatment of neoplasia comprising a Cox-2 inhibitor in combination with an epidermal growth factor receptor antagonist | Aug 28, 2003 | Abandoned |
Array
(
[id] => 7256095
[patent_doc_number] => 20040259811
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-23
[patent_title] => 'Chemotherapy method using x-rays'
[patent_app_type] => new
[patent_app_number] => 10/651307
[patent_app_country] => US
[patent_app_date] => 2003-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6985
[patent_no_of_claims] => 121
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0259/20040259811.pdf
[firstpage_image] =>[orig_patent_app_number] => 10651307
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/651307 | Chemotherapy method using x-rays | Aug 27, 2003 | Issued |
Array
(
[id] => 7389744
[patent_doc_number] => 20040037800
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-26
[patent_title] => 'Process for treating animal habitats'
[patent_app_type] => new
[patent_app_number] => 10/648993
[patent_app_country] => US
[patent_app_date] => 2003-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3335
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0037/20040037800.pdf
[firstpage_image] =>[orig_patent_app_number] => 10648993
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/648993 | Process for treating animal habitats | Aug 26, 2003 | Issued |
Array
(
[id] => 7398663
[patent_doc_number] => 20040039048
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-26
[patent_title] => 'Therapy with cannabinoid compounds for the treatment of brain tumors'
[patent_app_type] => new
[patent_app_number] => 10/647739
[patent_app_country] => US
[patent_app_date] => 2003-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 3881
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20040039048.pdf
[firstpage_image] =>[orig_patent_app_number] => 10647739
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/647739 | Therapy with cannabinoid compounds for the treatment of brain tumors | Aug 24, 2003 | Abandoned |
Array
(
[id] => 7207639
[patent_doc_number] => 20050043380
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-24
[patent_title] => 'Composition for treatment of malignant tumors'
[patent_app_type] => utility
[patent_app_number] => 10/642549
[patent_app_country] => US
[patent_app_date] => 2003-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 413
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0043/20050043380.pdf
[firstpage_image] =>[orig_patent_app_number] => 10642549
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/642549 | Composition for treatment of malignant tumors | Aug 17, 2003 | Abandoned |
Array
(
[id] => 7127834
[patent_doc_number] => 20050059578
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-17
[patent_title] => 'Compositions comprising phosphatidylethanolamine-binding peptides linked to anti-viral agents'
[patent_app_type] => utility
[patent_app_number] => 10/642121
[patent_app_country] => US
[patent_app_date] => 2003-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 53
[patent_figures_cnt] => 53
[patent_no_of_words] => 118989
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20050059578.pdf
[firstpage_image] =>[orig_patent_app_number] => 10642121
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/642121 | Compositions comprising phosphatidylethanolamine-binding peptides linked to anti-viral agents | Aug 14, 2003 | Issued |